Literature DB >> 24082381

Nonobstructive hypertrophic cardiomyopathy with left ventricular aneurysm: the role of cardiac magnetic resonance.

Faraz Khan Luni1, Ankush Moza, Mujeeb Sheikh, Melinda F Coker, Srivasvi K Chaganti, Terrence J Lewis, Yousuf Kanjwal.   

Abstract

Hypertrophic cardiomyopathy with concomitant left ventricular aneurysm is rare and has important clinical implications, including an increased risk of sudden cardiac death. Most patients with this rare combination have obstructive hypertrophic cardiomyopathy, but we treated a 26-year-old woman who had nonobstructive hypertrophic cardiomyopathy and a family history of probable sudden cardiac death. In our patient, coronary angiograms showed distal occlusion of the left anterior descending coronary artery. Late gadolinium-enhanced cardiac magnetic resonance images showed scattered fibrosis within and beyond the left ventricular aneurysm. Precautionary therapy with an implantable cardioverter-defibrillator yielded an uneventful outcome. Cardiac magnetic resonance has emerged as a promising method for diagnosing these aneurysms and detecting associated myocardial fibrosis, thereby enabling patient risk stratification and the determination of appropriate therapeutic options. We discuss the role of cardiac magnetic resonance imaging in the management of this rare clinical entity.

Entities:  

Keywords:  Cardiomyopathy, hypertrophic, familial/complications/pathology/therapy; coronary aneurysm/complications/diagnosis/therapy; death, sudden, cardiac/etiology; defibrillators, implantable; gadolinium/diagnostic use; image enhancement/instrumentation/methods; magnetic resonance imaging; risk assessment

Mesh:

Year:  2013        PMID: 24082381      PMCID: PMC3783143     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  12 in total

1.  Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia.

Authors:  Cameron J Holloway; Timothy R Betts; Stefan Neubauer; Saul G Myerson
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

2.  Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; John J Finley; J Martijn Bos; Thomas H Hauser; Warren J Manning; Tammy S Haas; John R Lesser; James E Udelson; Michael J Ackerman; Barry J Maron
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

3.  Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.

Authors:  Saidi A Mohiddin; Lameh Fananapazir
Journal:  Tex Heart Inst J       Date:  2002

Review 4.  Primary cardiac tumors.

Authors:  Monika J Leja; Dipan J Shah; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2011

5.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Rory O'Hanlon; Agata Grasso; Michael Roughton; James C Moon; Susan Clark; Ricardo Wage; Jessica Webb; Meghana Kulkarni; Dana Dawson; Leena Sulaibeekh; Badri Chandrasekaran; Chiara Bucciarelli-Ducci; Ferdinando Pasquale; Martin R Cowie; William J McKenna; Mary N Sheppard; Perry M Elliott; Dudley J Pennell; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

6.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Authors:  Deborah H Kwon; Randolph M Setser; Zoran B Popović; Maran Thamilarasan; Srikanth Sola; Paul Schoenhagen; Mario J Garcia; Scott D Flamm; Harry M Lever; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-19       Impact factor: 2.357

7.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

8.  Left ventricular aneurysm associated with apical hypertrophic cardiomyopathy.

Authors:  J Partanen; M Kupari; J Heikkilä; P Keto
Journal:  Clin Cardiol       Date:  1991-11       Impact factor: 2.882

9.  Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Authors:  Ronen Rubinshtein; James F Glockner; Steve R Ommen; Philip A Araoz; Michael J Ackerman; Paul Sorajja; J Martijn Bos; A Jamil Tajik; Uma S Valeti; Rick A Nishimura; Bernard J Gersh
Journal:  Circ Heart Fail       Date:  2009-10-22       Impact factor: 8.790

Review 10.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.